-+ 0.00%
-+ 0.00%
-+ 0.00%

Fortress Biotech Q4 EPS $(0.30) Beats $(0.42) Estimate, Sales $16.079M Miss $21.018M Estimate

Benzinga·03/31/2026 21:19:33
Listen to the news
Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.42) by 28.57 percent. This is a 15.38 percent decrease over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $16.079 million which missed the analyst consensus estimate of $21.018 million by 23.50 percent. This is a 6.34 percent increase over sales of $15.120 million the same period last year.